Brief: Jhbp Cy Says NMPA Accepts New Drug Application For Gb491 (Lerociclib)
13/03/2024 14:35
March 13 (Reuters) - Genor Biopharma Holdings Ltd
6998.HK :
* NATIONAL MEDICAL PRODUCTS ADMINISTRATION ACCEPTS NEW DRUG
APPLICATION FOR GB491 (LEROCICLIB)
Further company coverage: 6998.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Edding Genor group
See all newsBrief: Edding Genor Says CEO Initiates Plan To Purchase Additional Shares In Open Market
Brief: Edding Genor Posts Net Profit Increased To Rmb399.3 Million In 2025
Brief: Genor Biopharma Says NMPA Granted New Drug Application Approval For Lerociclib (Gb491)
Brief: Genor Biopharma, Its Unit & Edding Group Entered Into Merger Agreement
Brief: Genor Biopharma Says Guo Feng Tendered His Resignation As Chairman